Oncocyte Reports First Quarter 2024 Financial Results
15 mai 2024 16h05 HE
|
OncoCyte Corporation
ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Oncocyte to Announce First Quarter 2024 Financial Results
13 mai 2024 08h00 HE
|
OncoCyte Corporation
Oncocyte to Announce First Quarter 2024 Financial Results
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
07 mai 2024 09h19 HE
|
PRISM MarketView
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
Oncocyte Reports Full Year 2023 Financial Results
12 avr. 2024 06h00 HE
|
OncoCyte Corporation
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
11 avr. 2024 21h46 HE
|
OncoCyte Corporation
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
11 avr. 2024 17h30 HE
|
OncoCyte Corporation
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
09 avr. 2024 16h05 HE
|
OncoCyte Corporation
ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
16 janv. 2024 08h00 HE
|
OncoCyte Corporation
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico